San Francisco. The US Food and Drug Administration (FDA) has raised concerns over pulse oximeters that monitor blood oxygen levels in hospitals and at home. According to a US Food and Drug Administration (FDA) advisory panel, blood oxygen monitors need to be operated more carefully, as they do not work for people with darker skin.

During the pandemic in 2021, the US Food and Drug Administration (FDA) issued an alert saying that these devices have their limits.

An FDA panel report published in December 2020 suggests that pulse oximeters may be less accurate in patients with darker skin.

According to a study, the treatment of Kovid in black patients was delayed because the oxygen level in the devices did not show a drop.

Over-the-counter pulse oximeters or wellness devices are not reviewed by the FDA.

Estimation of the US pulse oximeter market shows an increase in the use of these devices during the first year of the COVID-19 pandemic.

“We need to take appropriate steps to address the uncertainty of these devices and ensure the health and safety of the public,” anesthesiologist Jesse Ehrenfeld told the panel, The Verge reports.

–IANS

read this also – Click to read the news of your state / city before the newspaper